According to a report by miragenews on March 21, Australian Health Minister Mark Butler introduced the "2024 Therapeutic Goods and Other Legislation Amendment (e-cigarette Reform) Bill" today. The bill aims to protect young people from the harms of e-cigarettes by prohibiting the manufacturing, advertising, supply, and commercial possession of non-therapeutic disposable e-cigarettes.
In conjunction with regulatory changes introduced earlier this year, the bill will restrict the import, distribution, and supply of all e-cigarettes and limit them solely to established pharmaceutical supply chains. Once the legislation takes effect, tobacco merchants, e-cigarette shops, and convenience stores will no longer be able to legally supply any type of e-cigarette, ensuring that patients can access e-cigarettes through legitimate channels.
At the same time, this bill includes a framework for illegal activities related to the import, manufacture, supply, advertisement, and commercialization of e-cigarettes, along with civil fines. Penalties for convicted offenders will be increased, with a maximum sentence of seven years imprisonment.
These reforms align with the guidelines of the Australian Tobacco Strategy 2023-2030.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
